title: So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control.
authors.affiliation: Departments of Vascular Biology and Immunology, The Scripps Research Institute, La Jolla, California 92037, USA. tse@scripps.edu
authors.forename: T S
authors.initials: TS
authors.lastname: Edgington
mesh_terms: D003324:Coronary Artery Disease / Q000150:complications* / Q000503:physiopathology*; D003328:Coronary Thrombosis / Q000209:etiology*; D006801:Humans